Officer and Director Transactions for Centessa Pharmaceuticals plc

This filing details transactions by Iqbal J. Hussain, Chief Legal Officer of Centessa Pharmaceuticals plc, on June 24, 2026. The transactions involved the disposition of 117,645 ordinary shares and 5,500 ordinary shares held indirectly. Additionally, options to purchase a total of 1,193,338 ordinary shares were disposed of. These transactions occurred concurrently with the acquisition of the company by Eli Lilly and Company through a scheme of arrangement. As part of this acquisition, shareholders received $38.00 in cash and a contingent value right (CVR) for each ordinary share. Share options were cancelled and converted into the right to receive cash equal to the excess of the cash consideration over the exercise price, plus one CVR per underlying share. Restricted Share Units also vested and were converted into cash and CVRs.